BLOG
Life Sciences
Postmarket Surveillance is Most Effective when Approached as an Enterprise Interest
FDA regulation 21 part 822 lays out the process, the rules, and the products that require postmarket surveillance. The [...]
Visit AssurX at the ASQ World Conference on Quality & Improvement [Booth 406]
AssurX, a leader in quality management software systems, will be exhibiting at the ASQ World Conference on Quality and I [...]
AssurX Names Stephanie McArdle as Vice President of Product Management for Life Sciences Industry
Morgan Hill, CA., May 16, 2019 -- AssurX, Inc. (AssurX), a leader in quality management and regulatory compliance softwa [...]
What to Make of FDA’s Secret Cache of Device Adverse Events
Last week an investigative report revealed the FDA has millions of “hidden” serious injury and malfunctions reports on m [...]
AssurX Receives HIPAA and HITECH Compliance Type 1 Attestation
Morgan Hill, CA – August 8, 2018 - AssurX,Inc. (AssurX), a leading provider of enterprise quality management and regulat [...]
Visit AssurX at the ASQ World Conference on Quality & Improvement (WCQI)
AssurX, a leader in quality management software systems, will exhibit at the 2018 ASQ World Conference on Quality & [...]
